Back to Agenda
Session 8, Tracks A, B: Digital Health Innovation and Rising Healthcare Technology Trends In Latin America and the Caribbean
Session Chair(s)
Urimara Argotti-Rodriguez, MBA
Regional Regulatory Policy LATAM Region, Global International Regulatory Policy , Productos Roche S.A. DE C.V., Mexico
Viktoria Magyar, LLM, MSC
Doctoral Student, Department of Regulatory and Quality Sciences, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
This session will highlight the digital revolution behind the economic growth and improvements in the field of healthcare with the use of new services and technologies. Emerging technologies like artificial-augmented intelligence (AI), machine learning (ML) and next-generation sequencing (NGS) technologies helped adopt emerging platform-based solutions, like telemedicine. These technologies also fast-tracked implementation trends of remote patient monitoring products to provide more cost-effective treatments, advanced surgical instruments, medical implants, diagnostic tools, pharmaceutical delivery solutions, and digital health platforms, all of which will be discussed. Global digital healthcare systems, regulatory innovation, and strategies needed to implement these efforts will also be reviewed.
Learning Objective : - Describe the aspects of digital health technologyies standards and technical guidance in Latin America
- Discuss how proper implementation of the digital transformation of healthcare can yield benefits in terms of service efficiency improvements and application of AI to healthcare delivery
- Encourage dialogue with Health Authorities to develop risk-based, fit-for-purpose regulatory frameworks to meet the needs of Software as Medical Device and AI, ML
Speaker(s)
Regulation of Drug Prescribing Information in Latin America and the Caribbean: e-labeling Challenges and Opportunities
Drug Regulatory Affairs Specialist, Roche Central America and the Caribbean, Costa Rica
Leveraging the Power of Digital Health to Improve Patient Outcomes in LATAM
Regulatory Policy Lead, Genentech, A Member of the Roche Group, United States
How Regulatory Innovation Drives Digital Health Connectivity Across Life Sciences: The Role of Industry and Regulators
Chief Strategy Officer, Rymedi, United States
Field Research on Current Labeling and Use Of Digital Labeling
Regulatory Affairs Director, Johnson & Johnson Innovative Medicine, Brazil
Have an account?